Skip to main content

Salvia divinorum, Hallucinogens, and the Determination of Medical Utility

  • Chapter
  • First Online:
Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use

Abstract

In 1970, The United States government enacted the Controlled Substances Act (CSA). The CSA usurped all existing federal laws regulating controlled substances and established three primary criteria for evaluating all drugs: medical utility, potential for abuse, and safety of the substance. Since the passage of the CSA, the federal government has generally taken the lead when regulating drugs; however, a psychoactive plant, Salvia divinorum, has illustrated some of the problems when evaluating hallucinogenic drugs under the current regulation scheme. Beginning in the late 1990s, S. divinorum began to appear for sale on the Internet and in “head shops,” often marketed as a “legal high.” The availability of a “legal high” has concerned many state lawmakers, but failed to gain the attention of federal drug regulators. To date, nearly half of the individual United States have chosen to regulate S. divinorum. One of the reasons for the regulation is that hallucinogens are not typically considered to have medical utility and have often been deemed to have no recognized medical utility. Furthermore, hallucinogens tend to be niche drugs with no real potential for abuse or addiction. As recently witnessed with the case of S. divinorum, the plant may not have a recognized medical utility, but the plant does not seem to present any real danger either. These circumstances can be problematic, since the rush to regulate a “legal high” seems to take precedence over determining if S. divinorum has medical utility.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Acker, C. J. (2002). Creating the American junkie: Addiction research in the classic era of narcotic control. Baltimore, MD: Johns Hopkins.

    Google Scholar 

  • Akers, R. L. (1992). Drugs, alcohol, and society: Social structure, process and policy. Belmont, CA: Wadsworth.

    Google Scholar 

  • Baggott, M. J., Erowid, E., Erowid, F., Galloway, G. P., & Mendelson, J. (2010). Use patterns of self-reported effects of Salvia divinorum: An Internet-based survey. Drug and Alcohol Dependence, 111(3), 250–256.

    Article  Google Scholar 

  • Blake, K. (2006, November 14). CBS 4 investigates herb “Salvia divinorum.” CBS 4 Investigates. Retrieved from http://cbs4denver.com/video/?id=24272@kcnc.dayport.com.

  • Bonnie, R. J., & Whitebread, C. H., II. (1999). The marijuana conviction: A history of marijuana prohibition in the United States (2nd ed.). New York, NY: The Lindesmith Center.

    Google Scholar 

  • Brecher, E. M., & the Editors of Consumer Reports (1972). Licit and illicit drugs. Boston, MA: Little Brown.

    Google Scholar 

  • Bucheler, R., Gleiter, C. H., Schwoerer, P., & Gaertner, I. (2005). Use of nonprohibited hallucinogenic plants: Increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (diviner’s sage). Pharmacopsychiatry, 38(1), 1–5.

    Article  Google Scholar 

  • Bullis, R. K. (2008). The “vine of the soul” vs. the controlled substances act: Implications of the hoasca case. Journal of Psychoactive Drugs, 40(2), 193–199.

    Article  Google Scholar 

  • Callaway, J. C., McKenna, D. J., Grob, C. S., Brito, G. S., Raymon, L. P., Poland, R. E., et al. (1999). Pharmacokinetics of hoasca alkaloids in healthy humans. Journal of Ethnopharmacology, 65(3), 243–256.

    Google Scholar 

  • Casselman, I., & Heinrich, M. (2011). Novel use patterns of Salvia divinorum: Unobtrusive observation using YouTube. Journal of Ethnopharmacology, 138(3), 662–667.

    Article  Google Scholar 

  • Courtwright, D. T. (1982). Dark paradise: A history of opiate addiction in America. Cambridge, MA: Harvard University Press.

    Google Scholar 

  • Courtwright, D. T. (2001). Forces of habit: Drugs and the making of the modern world. Cambridge, MA: Harvard University Press.

    Google Scholar 

  • Courtwright, D. T. (2004). The Controlled Substances act: How a “big tent” reform became a punitive drug law. Drug and Alcohol Dependence, 76(1), 9–15.

    Article  Google Scholar 

  • Dennehy, C. E., Tsourounis, C., & Miler, A. E. (2005). Evaluation of herbal dietary supplements marketed on the Internet for recreational use. The Annals of Pharmacotherapy, 39(10), 1634–1639.

    Article  Google Scholar 

  • Eisner, B. (1994). Ecstasy: The MDMA story (2nd ed.). Berkeley, CA: Ronin Publishing.

    Google Scholar 

  • Emboden, W. (1979). Narcotic plants: Hallucinogens, stimulants, inebriants, and hypnotics, their origins and uses. New York, NY: Macmillan.

    Google Scholar 

  • Engel, P. (1999, March 11). Testimony before the House Subcommittee on Oversight and Investigations of the 106th congress.

    Google Scholar 

  • Feeney, K., & Labate, B. C. (2014). The expansion of Brazilian ayahuasca religions: Law, culture and locality (this volume).

    Google Scholar 

  • Fischelis, R. P. (1938). What is a patent or proprietary medicine? The Scientific Monthly, 46(1), 25–31.

    Google Scholar 

  • Friedman, L. M. (1994). Crime and punishment in American history. New York, NY: Basic Books.

    Google Scholar 

  • Gahlinger, P. (2004). Illegal drugs: A complete guide to their history, chemistry, use and abuse. New York, NY: Plume Books.

    Google Scholar 

  • Gonzalez, D., Riba, J., Bouso, J. C., Gomez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157–162.

    Article  Google Scholar 

  • Goode, E. (2011). Drugs in American society (8th ed.). New York, NY: McGraw-Hill.

    Google Scholar 

  • Griffin, O. H., III, Miller, B. L., & Khey, D. N. (2008). Legally high? Legal considerations of Salvia divinorum. Journal of Psychoactive Drugs, 40(2), 183–191.

    Article  Google Scholar 

  • Griffiths, R. R., & Grob, C. S. (2010). Hallucinogens as medicine. Scientific American, 303, 77–79.

    Article  Google Scholar 

  • Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665.

    Article  Google Scholar 

  • Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283.

    Article  Google Scholar 

  • Grob, C. S., Mckenna, D. J., Callaway, J. C., Brito, G. S., Neves, E. S., Oberlaender, G., et al. (1996). Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil. The Journal of Nervous and Mental Disease, 184(2), 86–94.

    Article  Google Scholar 

  • Grundmann, O., Phipps, S. M., Zadezensky, I., & Butterweck, V. (2007). Salvia divinorum and salvinorin A: An update on pharmacology and analytical methodology. Planta Medica, 73(10), 1039–1046.

    Google Scholar 

  • Halpern, J. H., & Pope, H. G., Jr. (2001). Hallucinogens on the Internet: A vast new source of underground drug information. American Journal of Psychiatry, 158(3), 481–483.

    Article  Google Scholar 

  • Hawthorne, F. (2005). Inside the FDA: The business and politics behind the drugs we take and the food we eat. Hoboken, NJ: Wiley.

    Google Scholar 

  • Himmelstein, J. L. (1983). The strange career of marihuana: Politics and ideology of drug control in America. Westport, CT: Greenwood Press.

    Google Scholar 

  • Hofmann, A. (2005). LSD: My problem child: Reflections on sacred drugs, mysticism and science. Saline, MI: MAPS.

    Google Scholar 

  • Jaffe, J. A. (1985). Impact of scheduling on the practice of medicine and biomedical research. Drug and Alcohol Dependence, 14(3–4), 403–418.

    Article  Google Scholar 

  • Jenkins, P. (1999). Synthetic panics: The symbolic politics of designer drugs. New York, NY: New York University Press.

    Google Scholar 

  • Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22(6), 603–620.

    Article  Google Scholar 

  • Kelly, B. C. (2011). Legally tripping: A qualitative profile of Salvia divinorum use among young adults. Journal of Psychoactive Drugs, 43(1), 46–54.

    Article  Google Scholar 

  • Khey, D. N., Miller, B. L., & Griffin, O. H. (2008). Salvia divinorum use among a college student sample. Journal of Drug Education, 38(3), 297–306.

    Article  Google Scholar 

  • Labate, B. C., dos Santos, R. G., Anderson, B., Mercante, M., & Barbosa, P. C. R. (2012). The treatment and handling of substance dependence with ayahuasca: Reflections on current and future research. In B. C. Labate & E. MacRae (Eds.), Ayahuasca, ritual and religion in Brazil (pp. 205–227). Sheffield, UK: Equinox.

    Google Scholar 

  • Labate, B. C., & Feeney, K. (2012). Ayahuasca and the process of regulation in Brazil and internationally: Implications and challenges. International Journal of Drug Policy, 23(2), 154–161.

    Article  Google Scholar 

  • Lange, J. E., Daniel, J., Homer, K., Reed, M. B., & Clapp, J. D. (2010). Salvia divinorum: Effects and use among YouTube users. Drug and Alcohol Dependence, 108(1–2), 138–140.

    Article  Google Scholar 

  • Lange, J. E., Reed, M. B., Ketchie Croff, J. M., & Clapp, J. D. (2008). College student use of Salvia divinorum. Drug Alcohol Dependence, 94(1–3), 263–266.

    Article  Google Scholar 

  • Lee, M. A., & Shlain, B. (1994). Acid dreams: The complete social history of LSD. New York, NY: Grove Press.

    Google Scholar 

  • MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453–1461.

    Google Scholar 

  • McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129.

    Article  Google Scholar 

  • Miller, B. L., Griffin, O. H., III, Gibson, C. L., & Khey, D. N. (2009). Trippin’ on Sally D: Exploring predictors of Salvia divinorum experimentation. Journal of Criminal Justice, 37(4), 396–403.

    Article  Google Scholar 

  • Moran, T., & Culhane, M. (2007, October 3). Parents blame exotic plant for son’s suicide. ABC Nightline. Retrieved on September 29, 2012 from http://abcnews.go.com/Nightline/story?id=3685391&page=1#.UGZupVGAeSO.

  • Murphy, J., Kim A., Hagood, H., Richards, A., Augustine, C., Kroutil, L., & Sage, A. (2011, September). Twitter feeds and Google search query surveillance: Can they supplement survey data collection. Paper presented at Association for Survey Computing 6th International Conference, Bristol, UK.

    Google Scholar 

  • Musto, D. F. (1999). The American disease: Origins of narcotic control (3rd ed.). New York, NY: Oxford University Press.

    Google Scholar 

  • Perron, B. E., Ahmedani, B. K., Vaughn, M. G., Glass, J. E., Abdon, A., & Wu, L. (2012). Use of Salvia divinorum in a nationally representative sample. The American Journal of Drug and Alcohol Abuse, 38(1), 108–113.

    Article  Google Scholar 

  • Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage Salvia divinorum. Life Sciences, 78(5), 527–531.

    Article  Google Scholar 

  • Rasmussen, N. (2008). America’s first amphetamine epidemic 1929–1971: A quantitative and qualitative retrospective with implications for the present. American Journal of Public Health, 98(6), 974–985.

    Article  Google Scholar 

  • Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S. A., et al. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous k opioid selective agonist. Proceedings of the National Academy of Sciences of the United States of America, 99, 11934–11939.

    Google Scholar 

  • Santos, R. G., Landeira-Fernandez, J., Strassman, R. J., Motta, V., & Cruz, A. P. M. (2007). Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. Journal of Ethnopharmacology, 112(3), 507–513.

    Article  Google Scholar 

  • Schultes, R. E., Hofmann, A., & Ratsch, C. (2001). Plants of the gods: Their sacred, healing, and hallucinogenic powers. Rochester, VT: Healing Arts Press.

    Google Scholar 

  • Sheppard, S. G. (1994). A preliminary investigation of ibogaine: Case reports and recommendations for further study. Journal of Substance Abuse Treatment, 11(4), 379–385.

    Article  Google Scholar 

  • Siebert, D. J. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43(1), 53–56.

    Article  Google Scholar 

  • Siebert, D. J. (2006). The Salvia divinorum users guide. Retrieved on September 29, 2012 from http://sagewisdom.org/userguide.html.

  • Singh, S. (2007). Adolescent salvia substance abuse. Addiction, 102(5), 823–824.

    Article  Google Scholar 

  • Spillane, J. F. (2000). Cocaine: From medical marvel to modern menace in the United States, 1884–1920. Baltimore, MD: Johns Hopkins.

    Google Scholar 

  • Spillane, J. F. (2004). Debating the Controlled Substances Act. Drug and Alcohol Dependence, 76(1), 17–29.

    Article  Google Scholar 

  • Stogner, J., Khey, D. N., Griffin, O. H., III, Miller, B. L., & Boman, J. H., IV. (2012). Regulating a novel drug: An evolution of changes in use of Salvia divinorum in the first year of Florida’s ban. International Journal of Drug Policy, 23(6), 512–521.

    Article  Google Scholar 

  • Strassman, R. J. (1996). Human psychopharmacology of N,N-dimethyltryptamine. Behavioural Brain Research, 73(1–2), 121–124.

    Google Scholar 

  • Sutherland, E. H. (1940). White-collar criminality. American Sociological Review, 5(1), 1–12.

    Article  Google Scholar 

  • Valdes, L. J. (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26(3), 277–283.

    Article  Google Scholar 

  • Vohra, R., Seefeld, A., Cantrell, F. L., & Clark, R. F. (2011). Salvia divinorum: Exposures reported to a statewide poison control system over 10 years. The Journal of Emergency Medicine, 40(6), 643–650.

    Article  Google Scholar 

  • Vortherms, T. A., & Roth, B. L. (2006). Salvinorin A: From natural product to human therapeutics. Molecular Interventions, 6(5), 257–265.

    Article  Google Scholar 

  • Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets, Harvard University, 20(3), 77–84.

    Google Scholar 

  • Wu, L., Woody, G. E., Yang, C., Li, J., & Blazer, D. G. (2011). Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers. Substance Abuse Rehabilitation, 2011(2), 53–68.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. Hayden Griffin III .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Griffin, O.H. (2014). Salvia divinorum, Hallucinogens, and the Determination of Medical Utility. In: Labate, B., Cavnar, C. (eds) Prohibition, Religious Freedom, and Human Rights: Regulating Traditional Drug Use. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40957-8_8

Download citation

Publish with us

Policies and ethics